Scarica l'app Stockscreener
0.0999
1.11%
0.0011
Dopo l'orario di chiusura:
.10
0.0001
+0.10%
Precedente Chiudi:
$0.0988
Aprire:
$0.109
Volume 24 ore:
26.40M
Relative Volume:
0.80
Capitalizzazione di mercato:
$10.74M
Reddito:
-
Utile/perdita netta:
$-27.39M
Rapporto P/E:
-0.0595
EPS:
-1.6803
Flusso di cassa netto:
$-2.09M
1 W Prestazione:
-1.28%
1M Prestazione:
-73.88%
6M Prestazione:
-74.05%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.0988
$0.109
Intervallo di 1 settimana:
$0.0965
$0.112
Portata 52W:
$0.088
$2.10
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Nome
Aspire Biopharma Holdings Inc
Settore
Industria
Telefono
561-704-8527
Indirizzo
23150 FASHION DRIVE, SUITE 232, ESTERO
Confronta ASBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.0999 | 10.62M | 0 | -27.39M | -2.09M | -1.6803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.15 | 107.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.00 | 78.84B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.93 | 60.05B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
915.36 | 55.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.60 | 45.09B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - itemonline.com
Aspire Biopharma (NASDAQ: ASBP) Requests FDA Pre-IND Meeting on Sublingual AMI Aspirin - Stock Titan
ASBPWAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member - Morris County NJ News | Daily Record
ASBPAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan
Aspire Biopharma adds pioneering drug delivery expert to scientific team By Investing.com - Investing.com Nigeria
Aspire Biopharma adds pioneering drug delivery expert to scientific team - Investing.com
The time has not yet come to remove your chips from the table: Aspire Biopharma Holdings Inc (ASBP) - Setenews
What analysts say about Aspire Biopharma Holdings Inc stockFibonacci Retracement Levels & Small Budget Capital Growth - earlytimes.in
ASBPW Stock Institutional Owners - Quiver Quantitative
Nasdaq Stock Volume & Price Moves: Aspire Biopharma, NVIDIA, TeslaNews and Statistics - IndexBox
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Pensacola News Journal
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
3 Penny Stocks to Watch Now, 11/17/25 - TipRanks
Aspire Biopharma Holdings Inc (ASBP) looking to reclaim success with recent performance - Setenews
What analysts say about Drugs Made In America Acquisition Corp Equity Right stockAI-Driven Market Analysis & Explosive Capital Gains - earlytimes.in
Is Garnet International Limited Stock a Strong Buy According to Wall StreetFinancial Sector Performance & Minimal Investment Capital - earlytimes.in
Aspire Biopharma Holdings Inc Stock Analysis and ForecastRetail Trading Trends & Exceptional Profit Growth Tips - earlytimes.in
Aspire Biopharma Hldgs (ASBP) Stock Price, Quote, News & History - Benzinga
Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025 - ts2.tech
Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView
[8-K] Aspire Biopharma Holdings, Inc. Reports Material Event | ASBP SEC FilingForm 8-K - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Lohud
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025 - ts2.tech
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Prepare Yourself for Liftoff: Aspire Biopharma Holdings Inc (ASBP) - setenews.com
Aspire Biopharma Holdings, Inc. (ASBP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Aspire Biopharma reports positive reception at CPHI Frankfurt event - Investing.com India
Aspire Biopharma reports positive reception at CPHI Frankfurt event By Investing.com - Investing.com Nigeria
Aspire Biopharma (Nasdaq: ASBP) advances licensing talks after 16 CPHI meetings - Stock Titan
Aspire Biopharma Approves Key Proposals at Special Meeting - TipRanks
A look into Aspire Biopharma Holdings Inc (ASBP)’s deeper side - setenews.com
Aspire Biopharma announces resale of up to 11.26M shares - MSN
Penny Stocks To Watch TodayOctober 2nd - MarketBeat
What drives Aspire Biopharma Holdings Inc stock priceSell Signals and Alerts & Rapid Portfolio Investment - earlytimes.in
Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):